Related to Agilent and Sera Partner to Develop Proteomic Assays for Fetal and Maternal Health

• Reporting from J.P. Morgan on Tool and Service Providers
  2011 is expected to be the year of recovery.
  
• Instrumentation Firms Give Sugar Its Due, Developing Tools for Glycan-Protein Interaction Analysis
  Developers are working on analytical platforms to elucidate this latest omics field.
  
• R&D Direction in 2012 for Sequencing Technologies Is Aimed at Clinical Medicine
  Companies are focused on making these platforms smaller and easier to use.
  
• LAVAgel for Protein Diagnostics
  Researchers introduce a microfluidic, single-channel, multistage immunoblotting strategy toward scalable protein isoform analysis.
  
• Synthetic Degrons Play The N-End Game
  The Boc₃Arg moiety may provide a general strategy to construct inhibitors that induce targeted protein degradation.
  
• A Faster KAYAK: Mass Spectroscopy for Multiplexed Kinase Assays
  Researchers developed a new, simplified method for measuring the phosphorylation rates of peptide substrates.
  
• Look, No Label! Label-Free MST
  Two articles report on two methods that provided different levels of information on the differentiation of binding sites available on protein targets of interest.
  
• Literature Review: Protein—Now You See It, Now You Don't
  Researchers describe a system for the rapid and complete degradation of proteins in mammalian cells.
  
• Literature Review: A Flying Drop Becomes a Hanging Drop
  Researchers apply acoustic liquid-transfer technology to protein crystallization.